5-Amino-1MQ Literature Review: Key Preclinical Papers
This literature review synthesizes published preclinical evidence evaluating 5-amino-1mq, a selective membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). Researchers analyze 5-amino-1mq studies to understand its role in modulating cellular NAD+ pools, expanding mitochondrial output, and influencing metabolic pathways in cell culture and animal models. All compounds discussed are strictly designated for laboratory research use only.
Quick answer
This literature review synthesizes published preclinical evidence evaluating 5-amino-1mq, a selective membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). Researchers analyze 5-amino-1mq studies to understand its role in modulating cellular NAD+ pools, expanding mitochondrial output, and influencing metabolic pathways in cell culture and animal models. All compounds discussed are strictly designated for laboratory research use only.
Key takeaways
- Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme primarily expressed in metabolic tissues, including white adipose tissue, the liver, and skeletal muscle.
- The enzymatic kinetics of [5-amino-1mq](/research-peptides/5-amino-1mq) have been documented in several cell-free and biochemical assays.
- A foundational focus of published [5-amino-1mq](/research-peptides/5-amino-1mq) studies centers on intracellular nucleotide dynamics.
- Replenishing intracellular [NAD+](/research-peptides/nad-plus) pools directly impacts mitochondrial function due to the essential role of NAD+ as an electron carrier in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation.
Introduction to NNMT Biology and 5-Amino-1MQ
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme primarily expressed in metabolic tissues, including white adipose tissue, the liver, and skeletal muscle. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because nicotinamide is a critical precursor in the salvage pathway that generates nicotinamide adenine dinucleotide (NAD+), excessive NNMT activity drains cellular NAM and SAM reserves, impairing bioenergetic efficiency and methyl group homeostasis.
5-Methylquinoliniom (5-amino-1mq) was identified through structural modeling and high-throughput enzymatic screening as a potent, small-molecule inhibitor of NNMT. Unlike native substrates, 5-amino-1mq exhibits high membrane permeability and high selectivity for NNMT over related methyltransferases. Laboratory investigations using 5-Amino-1MQ (5mg) focus on reversing NNMT-mediated NAD+ depletion in cultured cell lines and rodent models, providing a molecular tool to probe metabolic control mechanisms without modifying gene expression directly.
Enzymatic Mechanism of Action: Selective NNMT Inhibition
The enzymatic kinetics of 5-amino-1mq have been documented in several cell-free and biochemical assays. Published literature indicates that 5-amino-1mq acts as a competitive inhibitor against the substrate nicotinamide and an uncompetitive or mixed-type inhibitor relative to SAM. Biochemical binding assays demonstrate a low-micromolar inhibition constant (IC50 ~ 1.2 to 2.5 µM), effectively blocking the enzymatic conversion of NAM into 1-MNA.
By inhibiting NNMT activity, 5-amino-1mq prevents the irreversible loss of nicotinamide through excretion as 1-MNA. This preservation allows NAM to remain available for conversion into nicotinamide mononucleotide (NMN) via nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the NAD+ salvage pathway. Preclinical evidence suggests that this mechanism circumvents the negative feedback loops frequently observed with direct precursor supplementation, sustaining intracellular NAD+ synthesis under high-demand or metabolic stress conditions.
Preclinical Data on Cellular NAD+ Dynamics and Methyl Donors
A foundational focus of published 5-amino-1mq studies centers on intracellular nucleotide dynamics. In vitro assays using 3T3-L1 adipocytes and primary human myoblasts demonstrate that NNMT inhibition leads to a statistically significant elevation in intracellular NAD+ levels compared to untreated controls. Researchers observed that treating adipocytes with 5-amino-1mq restored NAD+ concentrations to baseline levels in models characterized by elevated NNMT expression.
Furthermore, because NNMT consumes SAM during methyl transfer, over-expression of NNMT reduces the SAM/SAH ratio—a crucial metric of cellular methylation potential. Studies evaluating histone methylation marks report that application of 5-amino-1mq restores the SAM/SAH balance in vitro. This preservation of methyl donor pools influences epigenetic regulation, as altered SAM availability impacts methyltransferase enzymes responsible for histone and DNA methylation.
Mitochondrial Respiration and Energy Expenditure in Model Systems
Replenishing intracellular NAD+ pools directly impacts mitochondrial function due to the essential role of NAD+ as an electron carrier in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. Extracellular flux analysis (Seahorse bioenergetic profiling) in rodent skeletal muscle cells treated with 5-amino-1mq demonstrated marked increases in basal oxygen consumption rate (OCR) and maximal respiratory capacity.
Preclinical reports attribute these bioenergetic changes to the activation of NAD+-dependent deacetylases, specifically sirtuin 1 (SIRT1). Elevated NAD+ availability enhances SIRT1 enzymatic activity, leading to the deacetylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). In animal models, increased PGC-1α activity correlates with upregulated transcription of mitochondrial genes, increased mitochondrial mass, and elevated expression of uncoupling proteins (UCP-1 in brown/beige adipose tissues), driving non-shivering thermogenesis.
Adipose Tissue Remodeling and Lipid Metabolism Studies
In vivo investigations using diet-induced obese (DIO) mice have provided extensive data regarding the effects of NNMT inhibition on adipose tissue composition. In a landmark study examining high-fat diet rodent models, systemic administration of an NNMT inhibitor resulted in a significant reduction in adipocyte cell size (hypertrophy suppression) and a reduction in total white adipose tissue (WAT) mass without alterations in daily caloric intake.
Transcriptomic profiling of adipose tissue isolated from treated animals revealed downregulation of lipogenic genes, including fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC). Simultaneously, lipid oxidation pathways were upregulated. Researchers concluded that 5-amino-1mq studies demonstrate a cell-autonomous mechanism wherein NNMT suppression increases baseline metabolic rate in fat tissue, preventing the lipid accumulation typically induced by high-fat dietary interventions.
Skeletal Muscle Function and Myogenesis Research
Beyond adipose tissue, NNMT expression is upregulated in aging or injured skeletal muscle tissue, where high activity correlates with impaired regenerative capacity. Preclinical studies evaluating aged mouse models demonstrated that aged muscle stem cells (satellite cells) exhibit compromised proliferation due to NAD+ depletion and altered epigenetic landscapes.
In vitro and ex vivo tissue assays showed that treating senescent myoblasts with 5-amino-1mq accelerated myotube formation, increased myotube diameter, and restored muscle stem cell activation following injury. Subsequent functional testing in rodent injury models reported faster recovery of peak isometric twitch force in treated groups compared to vehicle controls, highlighting 5-amino-1mq as a key research tool for investigating sarcopenia and neuromuscular degeneration.
Comparative Analysis: 5-Amino-1MQ and Related Metabolic Modulators
To contextualize the preclinical profile of 5-amino-1mq, researchers frequently compare its mechanism to other metabolic modulators in our catalog of research compounds. While 5-amino-1mq functions as a direct enzymatic inhibitor of NNMT, alternative candidates modulate metabolic output through distinct signaling cascades. For example, MOTS-c study summary documents how mitochondrial-derived peptides regulate folate-dependent purine biosynthesis and activate AMPK, whereas compounds like AICAR directly stimulate AMPK by mimicking AMP.
In experimental models evaluating lipid utilization and mitochondrial biogenesis, 5-amino-1mq is often studied alongside AICAR and GW501516. Unlike direct AMPK agonists or PPAR-delta ligands, 5-amino-1mq acts upstream on nucleotide salvaging, raising endogenous NAD+ without directly binding metabolic transcription factors. Combining or comparing these agents in vitro allows laboratories to dissect the discrete contributions of SIRT1 activation versus AMPK phosphorylation in cellular metabolic regulation. Explore our broader PX1 research library for detailed mechanistic overviews of these complementary research tools.
Methodological Considerations for In Vitro and Animal Protocols
When designing protocols for 5-amino-1mq studies, researchers must account for solubilization and stability characteristics. 5-Amino-1mq is highly soluble in dimethyl sulfoxide (DMSO) and moderately soluble in aqueous buffers at specific pH ranges. For cell culture experiments, working concentrations typically range between 1 µM and 10 µM, with exposure times spanning 24 to 72 hours depending on the primary endpoint (e.g., enzyme kinetics vs. transcriptomic shifts).
For animal studies, vehicle formulation requires careful optimization to ensure uniform delivery and bio-availability. Research protocols reported in published literature utilize daily parenteral or oral administration, tracking parameters such as respiratory exchange ratio (RER), body composition via EchoMRI, and serum metabolite profiles over 10 to 28 days. Accurate mass calculations for reconstituting lyophilizates or dry powders can be verified using the PX1 reconstitution calculator.
Quality Verification and Laboratory Standards
The reliability of preclinical data depends on the structural integrity and purity of the chemical reagents employed. Contaminants, unreacted intermediates, or residual solvents in low-grade research compounds can induce off-target cytotoxic effects in cell culture or obscure metabolic endpoints in animal models.
PX1 Research enforces strict quality assurance for every lot manufactured in our USA facilities. Each batch of 5-amino-1mq undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to verify chemical identity, molar purity (>98%), and stability. Furthermore, lot-specific testing is conducted in ISO 17025 accredited facilities to ensure endotoxin levels remain below stringent limits for cell culture and preclinical applications. Verified documentation for every batch is accessible via our Certificate of Analysis (COA) portal. Laboratory administrators seeking bulk allocations or institutional supply agreements can apply through our wholesale lab account portal.
Frequently Asked Questions
What is the primary target evaluated in 5-amino-1mq studies?
5-Amino-1MQ is a selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that regulates NAD+ salvage pathways and cellular methylation dynamics.
How does 5-amino-1mq elevate cellular NAD+ levels in preclinical models?
By inhibiting NNMT, 5-amino-1mq prevents the methylation and excretion of nicotinamide (NAM). This preserves NAM so it can be recycled via the NAMPT salvage pathway into NAD+.
Is 5-Amino-1MQ classified as a peptide or a small molecule?
5-Amino-1MQ is a synthetic quinolinium derivative classified as a membrane-permeable small-molecule enzyme inhibitor, distinct from amino acid chain peptides.
What purity standards are required for 5-amino-1mq in research applications?
Preclinical assays require high chemical purity (typically >98% confirmed via HPLC/MS) and low endotoxin levels to avoid off-target cytotoxicity or inflammatory confounding in cell and animal models.
How should 5-Amino-1MQ be solubilized for in vitro assays?
5-Amino-1MQ is typically dissolved in high-purity DMSO to create stock solutions, which are subsequently diluted into aqueous culture media to achieve desired experimental concentrations (e.g., 1–10 µM).
Where can researchers obtain lot-specific analytical data for 5-Amino-1MQ?
PX1 Research provides comprehensive, lot-specific Certificates of Analysis (COA) detailing HPLC purity and mass spectrometry validation directly through our dedicated COA portal.
Can 5-Amino-1MQ be combined with other metabolic compounds in laboratory studies?
Yes, investigators frequently design comparative or co-treatment studies involving 5-amino-1mq alongside AMPK activators or mitochondrial peptides to delineate distinct metabolic signaling networks.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.